Longeveron Inc. (LGVN)
NASDAQ·Healthcare·Biotechnology
$0.60
-1.03%
Mkt Cap $20.97M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
+1580.4%
Consensus $10.00 vs current $0.60
NASDAQ·Healthcare·Biotechnology
$0.60
-1.03%
Mkt Cap $20.97M
Buy
1
Hold
1
Sell
0
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
+1580.4%
Consensus $10.00 vs current $0.60